Werner HMJ - Search Results

1

Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer.

Lindemann K, Smogeli E, Småstuen MC, Bruheim K, Trovik J, Nordberg T, Kristensen GB, Werner HMJ, Nakken E. Lindemann K, et al. Among authors: werner hmj. Cancers (Basel). 2021 Mar 18;13(6):1367. doi: 10.3390/cancers13061367. Cancers (Basel). 2021. PMID: 33803531 Free PMC article.

2

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification.

Kasius JC, Pijnenborg JMA, Lindemann K, Forsse D, van Zwol J, Kristensen GB, Krakstad C, Werner HMJ, Amant F. Kasius JC, et al. Among authors: werner hmj. Cancers (Basel). 2021 Nov 22;13(22):5848. doi: 10.3390/cancers13225848. Cancers (Basel). 2021. PMID: 34831000 Free PMC article. Review.

3

Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.

Njølstad TS, Engerud H, Werner HM, Salvesen HB, Trovik J. Njølstad TS, et al. Gynecol Oncol. 2013 Nov;131(2):410-5. doi: 10.1016/j.ygyno.2013.08.032. Epub 2013 Sep 1. Gynecol Oncol. 2013. PMID: 24004646

4

Improved survival related to changes in endometrial cancer treatment, a 30-year population based perspective.

Trovik J, Mauland KK, Werner HM, Wik E, Helland H, Salvesen HB. Trovik J, et al. Gynecol Oncol. 2012 May;125(2):381-7. doi: 10.1016/j.ygyno.2012.01.050. Epub 2012 Feb 1. Gynecol Oncol. 2012. PMID: 22307064

5

Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial Cancer.

Yang JY, Werner HM, Li J, Westin SN, Lu Y, Halle MK, Trovik J, Salvesen HB, Mills GB, Liang H. Yang JY, et al. Clin Cancer Res. 2016 Jan 15;22(2):513-23. doi: 10.1158/1078-0432.CCR-15-0104. Epub 2015 Jul 29. Clin Cancer Res. 2016. PMID: 26224872 Free PMC article.

6

Androgen receptor as potential therapeutic target in metastatic endometrial cancer.

Tangen IL, Onyango TB, Kopperud R, Berg A, Halle MK, Øyan AM, Werner HM, Trovik J, Kalland KH, Salvesen HB, Krakstad C. Tangen IL, et al. Oncotarget. 2016 Aug 2;7(31):49289-49298. doi: 10.18632/oncotarget.10334. Oncotarget. 2016. PMID: 27384477 Free PMC article.

7

Type of vascular invasion in association with progress of endometrial cancer.

Visser NCM, Werner HMJ, Krakstad C, Mauland KK, Trovik J, Massuger LFAG, Nagtegaal ID, Pijnenborg JMA, Salvesen HB, Bulten J, Stefansson IM. Visser NCM, et al. Among authors: werner hmj. APMIS. 2017 Dec;125(12):1084-1091. doi: 10.1111/apm.12774. Epub 2017 Oct 4. APMIS. 2017. PMID: 28975668

8

Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.

Werner HM, Trovik J, Halle MK, Wik E, Akslen LA, Birkeland E, Bredholt T, Tangen IL, Krakstad C, Salvesen HB. Werner HM, et al. PLoS One. 2014 Feb 25;9(2):e90141. doi: 10.1371/journal.pone.0090141. eCollection 2014. PLoS One. 2014. PMID: 24587245 Free PMC article.

9

Switch in FOXA1 status associates with endometrial cancer progression.

Tangen IL, Krakstad C, Halle MK, Werner HM, Oyan AM, Kusonmano K, Petersen K, Kalland KH, Akslen LA, Trovik J, Hurtado A, Salvesen HB. Tangen IL, et al. PLoS One. 2014 May 21;9(5):e98069. doi: 10.1371/journal.pone.0098069. eCollection 2014. PLoS One. 2014. PMID: 24849812 Free PMC article.

10

Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions.

Tangen IL, Werner HM, Berg A, Halle MK, Kusonmano K, Trovik J, Hoivik EA, Mills GB, Krakstad C, Salvesen HB. Tangen IL, et al. Eur J Cancer. 2014 Nov;50(17):3003-10. doi: 10.1016/j.ejca.2014.09.003. Epub 2014 Sep 30. Eur J Cancer. 2014. PMID: 25281525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page